PEPTIDEPEDIA.US
All peptides
Hormones & Reproductive HealthGrade A

Kisspeptin

Also known as Kisspeptin-10 (KP-10), Kisspeptin-54 (KP-54), metastin

A naturally occurring hypothalamic signaling peptide that acts upstream of GnRH and plays a central role in regulating the reproductive hormone axis.

Regulatory status
Investigational / research peptide

Kisspeptin has been investigated extensively in human reproductive endocrinology research but should not be represented as an FDA-approved therapeutic drug.

Half-life
Isoform dependent (see below)
  • Kisspeptin-10 (KP-10)Very short acting; plasma levels fall rapidly following administration.
  • Kisspeptin-54 (KP-54)Approximately 28 minutes to 1.8 hours reported in human studies.

Half-life depends on the kisspeptin isoform and route of administration.

Route
Intravenous and subcutaneous in clinical research

Newer research has evaluated alternative delivery approaches, but these remain investigational. Injection use is not a validated routine medical treatment.

Evidence
Multiple randomized controlled trials in humans

Mechanism of action

Kisspeptin binds the KISS1 receptor (KISS1R/GPR54) on hypothalamic GnRH neurons, stimulating endogenous gonadotropin-releasing hormone release. GnRH in turn stimulates the anterior pituitary to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which regulate gonadal function including ovarian activity, spermatogenesis, and sex-steroid production.

KisspeptinKISS1RGnRHPituitaryLH + FSHGonadal function

Studied and reported uses

  • Reproductive hormone stimulation

    Human studies demonstrate that kisspeptin can stimulate endogenous GnRH and increase circulating LH, with effects on FSH depending on physiological context.

  • Fertility and reproductive medicine research

    Kisspeptin has been investigated as a method of activating the reproductive axis and as an experimental trigger for oocyte maturation in assisted-reproduction research.

  • Hypogonadotropic reproductive disorders

    Research has investigated whether stimulation of the kisspeptin-GnRH pathway may help restore or assess hypothalamic reproductive signaling.

  • Male reproductive hormone research

    Administration of kisspeptin has been shown in human studies to stimulate LH and can subsequently influence testosterone production.

  • Female reproductive physiology

    Kisspeptin plays an important physiological role in menstrual-cycle regulation, GnRH signaling, and the pre-ovulatory LH surge.

  • Diagnostic/research assessment of the HPG axis

    Responses to kisspeptin have been investigated as a potential research tool for assessing hypothalamic-pituitary-gonadal function.

Dosing information

Clinical researchNo universally established therapeutic dosing regimen exists.
Formulations studiedHuman studies have investigated Kisspeptin-10 and Kisspeptin-54 using various experimental administration strategies.

Ranges are reported from literature and clinical labeling for reference only. They are not a dosing recommendation.

Study ranges vary significantly depending on kisspeptin isoform, route, sex, reproductive state, and research objective. Published research protocols should not be interpreted as routine clinical dosing recommendations.

Important pharmacology

Physiological signaling

Unlike administering LH, hCG, or testosterone directly, kisspeptin acts farther upstream in the reproductive axis by stimulating endogenous GnRH signaling. Downstream hormonal responses therefore depend on an intact hypothalamic-pituitary-gonadal axis.

Tachyphylaxis / desensitization

Repeated or continuous kisspeptin exposure may produce different endocrine responses from intermittent exposure. Research has demonstrated that response depends on dose, duration, isoform, sex, and reproductive state.

Side effects

  • Headache
  • Flushing
  • Light-headedness
  • Transient hormonal changes
  • Injection-site discomfort in injection studies

Human research studies have generally reported good short-term tolerability, but long-term therapeutic safety data remain limited.

Research evidence

Human endocrine studies

Kisspeptin-10 and Kisspeptin-54 have both been demonstrated to stimulate the human reproductive hormone axis, particularly LH secretion.

Healthy male studies

Controlled human studies demonstrate marked stimulation of LH following kisspeptin administration, with downstream effects on reproductive hormones.

Female reproductive studies

Response to kisspeptin varies according to menstrual-cycle stage and estrogen environment, demonstrating strong physiological context dependence.

Assisted reproduction research

Kisspeptin-54 has been investigated as an experimental trigger for final oocyte maturation during IVF treatment.

GnRH comparison studies

Direct human comparisons indicate that kisspeptin stimulates endogenous GnRH signaling, although GnRH itself can produce stronger gonadotropin responses under some experimental conditions.

Scientific references

  • Kisspeptin signalling in reproductive biology (KISS1R/GPR54 → GnRH)

    Nature Reviews Endocrinology / PubMed-indexed reviews of KISS1R physiology

  • Kisspeptin-54 stimulates gonadotrophin release in human volunteers

    Journal of Clinical Endocrinology & Metabolism (PubMed-indexed)

  • Kisspeptin-10 infusion increases LH secretion in healthy men

    Journal of Clinical Endocrinology & Metabolism (PubMed-indexed)

  • Pharmacokinetics and half-life of kisspeptin-54 in humans

    Clinical endocrinology pharmacokinetic studies (PubMed-indexed)

  • Kisspeptin responses across the menstrual cycle in women

    Human Reproduction / JCEM (PubMed-indexed)

  • Kisspeptin-54 as an oocyte maturation trigger in IVF

    Journal of Clinical Investigation; ClinicalTrials.gov registered trials

  • Comparative kisspeptin vs GnRH gonadotropin response studies

    PubMed-indexed controlled human comparison studies

  • Investigational status of kisspeptin analogues

    FDA drug approval databases and ClinicalTrials.gov records